title: Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels.
authors.affiliation: Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
authors.forename: F M
authors.initials: FM
authors.lastname: Sacks
authors.forename: J L
authors.initials: JL
authors.lastname: Rouleau
authors.forename: L A
authors.initials: LA
authors.lastname: Moye
authors.forename: M A
authors.initials: MA
authors.lastname: Pfeffer
authors.forename: J W
authors.initials: JW
authors.lastname: Warnica
authors.forename: J M
authors.initials: JM
authors.lastname: Arnold
authors.forename: D T
authors.initials: DT
authors.lastname: Nash
authors.forename: L E
authors.initials: LE
authors.lastname: Brown
authors.forename: F
authors.initials: F
authors.lastname: Sestier
authors.forename: J
authors.initials: J
authors.lastname: Rutherford
mesh_terms: D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000924:Anticholesteremic Agents; D002784:Cholesterol